Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses. uri icon

authors

  • Gauvreau, Gail M
  • Killian, Kieran J
  • Laviolette, Michel
  • Carlsten, Christopher
  • Lazarinis, Nikolaos
  • Watson, Richard M
  • Milot, Joanne
  • Swystun, Veronica
  • Bowen, Miranda
  • Hui, Linda
  • Lantz, Ann-Sofie
  • Arm, Jonathan P
  • Meiser, Karin
  • Maahs, Suzanne
  • Lowe, Philip J
  • Skerjanec, Andrej
  • Drollmann, Anton
  • O'Byrne, Paul M
  • Boulet, Louis-Philippe
  • Leigh, Richard
  • Cockcroft, Donald W
  • Davis, Beth E
  • Mayers, Irvin
  • FitzGerald, J Mark
  • Dahlen, Barbro

publication date

  • January 1, 2016